<?xml version="1.0" encoding="UTF-8"?>
<p>The beneficial effects of 
 <italic>Hericium erinaceus</italic> have been demonstrated in numerous clinical studies. Mori et al. [
 <xref rid="B109-ijms-22-00634" ref-type="bibr">109</xref>], for example, conducted a double-blind, parallel-group, placebo-controlled clinical trial with 30 middle cognitive impairment patients, giving them four 250 mg tablets containing 96% mushroom powder or placebo three times a day for 16 weeks, continuing the follow-up for a further 4 weeks and performing assessments using a cognitive function scale based on the Revised Hasegawa Dementia Scale (HDS-R).
</p>
